Clinical trial
A Multicenter Open-Label Multi-Cohort Dose-Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of GNR-051 (GENERIUM JSC, Russia) in Subjects With Solid Advanced Malignancies
NCT04544748 is registered in ClinicalTrials.gov with AO GENERIUM as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Open-Label Multi-Cohort Dose-Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of GNR-051 (GENERIUM JSC, Russia) in Subjects With Solid Advanced Malignancies
- Lead sponsor
- AO GENERIUM
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 22, 2020
- Completion date
- December 25, 2023
- Enrollment
- 48 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.